Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00673244 · ClinicalTrials.gov registry record · NA
Protocol to Assess the Severity of Acute Kidney Injury
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT00673244 is a NA study that has completed, run by George Washington University. The registered enrollment target is 77 participants.
The verdict
NCT00673244, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The principal objective is to safely determine if we can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled, we will draw blood and urine for relevant biomarkers. Our goal is to validate if any of these biomarkers can predict the course of AKI (recovery v. RRT v. death)
Interventions
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2008-04 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00673244
The ClinicalTrials.gov registry entry for NCT00673244 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Furosemide is the first listed.
NCT00673244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00673244 about?
NCT00673244 is a clinical study titled "Protocol to Assess the Severity of Acute Kidney Injury". The principal objective is to safely determine if we can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled, we will draw blood and urine for relevant biomarkers. Our goal is to validate if any of these biomarkers can predict the course of AKI (recov...
What is the current status of trial NCT00673244?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2008-04. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00673244?
The interventions under investigation include: Furosemide (DRUG).
Who is sponsoring clinical trial NCT00673244?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.